ISSN 2305-3127 (Print)   
ISSN 2664-3790 (Online)

 

Chronic coronary occlusions in patients after coronary artery bypass grafting. Morphological features and a review of possible interventions

 S.М. Furkalo

References

  1. Alhejily WA, et al. Retrograde approach to coronary chronic total occlusion via an occluded saphenous bypass graft: a case report. Clin Case Rep. 2013;1(2):54-58.
  2.  Borges JC, et al. Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery. J Cardiothorac Surg. 2010;5:91.
  3. Brilakis ES, et al. Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2011;4(8):844-850.
  4. Brilakis ES, et al. Retrograde recanalization of native coronary artery chronic occlusions via acutely occluded vein grafts. Catheter Cardiovasc Interv. 2010;75(1):109-113.
  5. Burke AP, et al. Pathophysiology of calcium deposition in coronary arteries. Herz. 2001;26(4):239-244.
  6. Chen L, et al. Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass surgery. J Am Coll Cardiol. 1996;28(6):1493-1499.
  7. Chiu JJ, Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol. Rev. 2011;91(1):327-387.
  8. Goldman S, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol. 2004;44(11):2149-2156.
  9. Hsu JT, et al. Impact of calcification length ratio on the intervention for chronic total occlusions. Int. J. Cardiol. 2011;150(2):135-141.
  10. Hwang M, et al. Progression of native coronary artery disease at 10 years: insights from a randomized study of medical versus surgical therapy for angina. J. Am. Coll. Cardiol. 1990;16(5):1066-1070.
  11. Joyal D, et al. Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis. Am Heart J. 2010;160(1):179-187.
  12. Kitamura S. Physiological and metabolic effects of grafts in coronary artery bypass surgery. Circ J. 2011;75(4):766-772.
  13. Lee MS, et al. Saphenous vein graft intervention. JACC Cardiovasc Interv. 2011;4(8):831-843.
  14.  Lichtenwalter C, et al. Dual guide catheter technique for treating native coronary artery lesions through tortuous internal mammary grafts: separating equipment delivery from target lesion visualization. J Invasive Cardiol. 2010;22(5):E78-81.
  15. Maurer BJ, et al. Changes in grafted and nongrafted coronary arteries following saphenous vein bypass grafting. Circulation. 1974;50(2):293-300.
  16. Marmagkiolis K, et al. Saphenous vein graft perforation during percutaneous coronary intervention: a case series. J Invasive Cardiol. 2013;25(3):157-161.
  17. Michael TT, et al. Impact of prior coronary artery bypass graft surgery on chronic total occlusion revascularisation: insights from a multicentre US registry. Heart. 2013;99(20):1515-1518.
  18. Michael TT, et al. Role of internal mammary artery bypass grafts in retrograde chronic total occlusion interventions. J Invasive Cardiol. 2012;24(7):359-362.
  19. Peterson ED, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol. 2010;55(18):1923-1932.
  20. Rathore S, et al. Retrograde percutaneous recanalization of chronic total occlusion of the coronary arteries: procedural outcomes and predictors of success in contemporary practice. Circ Cardiovasc Interv. 2009;2(2):124-132.
  21. Sakakura K, et al. Comparison of pathology of chronic total occlusion with and without coronary artery bypass graft. Eur Heart J. 2014;35(25):1683-1693.
  22. Sekiguchi M, et al. Retrograde percutaneous coronary intervention via critically degenerated saphenous vein grafts for chronic total occlusion in native coronary arteries. WJCD. 2013;3(3):261-265.
  23. Sianos G, et al. Recanalisation of chronic total coronary occlusions: 2012 consensus document from the EuroCTO club. EuroIntervention. 2012;8(1):139-145.
  24. Tarr F.I, et al. Evidence of nitric oxide produced by the internal mammary artery graft in venous drainage of the recipient coronary artery. Ann Thorac Surg. 2005;80(5):1728-1731.
  25. Touma G, et al. Chronic total occlusions - Current techniques and future directions. IJC Heart & Vasculature. 2015;7:28-39.
  26. Torii S, et al. Retrograde approach via left internal mammary artery using a 5 Fr guiding catheter. Cardiovasc Interv Ther. 2015. [Epub ahead of print]
  27. Varghese I, et al. Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgery. Cardiovasc Revasc Med. 2009;10(2):103-109.
  28. Werner GS, et al. Effect of acetylcholine on arterial and venous grafts and coronary arteries in patients with coronary artery disease. Eur Heart J. 1990;11(2):127-137.
  29. Yang CF, et al. Successful Revascularization of Chronic Total Occlusion in Native Coronary Arteries through an Occluded Saphenous Bypass Vein Graft: A Retrograde Alternative Approach. Acta Cardiol Sin. 2014;30:485-489. 

 

[PDF] [Contents]  

  

 

Global longitudinal strain and its dynamics after replacement of aortal valve in patients with severe aortic stenosis

N.V. Ponych, O.O. Nemchyna, O.J. Zharinov, O.A. Yepanchintseva, B.M. Todurov

References

  1. Kovalenko VM, Nesukai OG, Polenova NS, Titov YeYu, Danylenko OO. Reference values and role of speckle tracking echocardiography in assessment of systolic and diastolic function. Ukrainian Journal of Cardiology. 2012;6:103-109. (in Ukr.).
  2. Adda J, Mielot C, Giorgi R, et al. Low-flow, low-gradient severe aortic stenosis despite normal ejection fraction is associated with severe left ventricular dysfunction as assessed by speckle-tracking echocardiography: a multicenter study. Circ Cardiovasc Imaging. 2012;5:27-35.
  3. Amundsen BH, Helle-Valle T, Edvardsen T, et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol. 2006;47:789-793.
  4. Aurigemma GP, Silver KH, Priest MA, et al. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol. 1995;26:195-202.
  5. Baumgartner H, Hung J, Bermejo J, et al. EAE/ASE recommendations of echocardiographic assessment of aortic stenosis: a focused update from the European Association of Cardiovascular Imaging and American Society of Echocardiology. Eur Heart J Cardiovasc Imaging. 2017;18(3):254-275.
  6. Carasso S, Cohen O, Mutlak D, et al. Differential effects of afterload on left ventricular long- and short-axis function: insights from a clinical model of patients with aortic valve stenosis undergoing aortic valve replacement. Am Heart J. 2009;158:540-545.
  7.  Carasso S, Cohen O, Mutlak D, et al. Relation of myocardial mechanics in severe aortic stenosis to left ventricular ejection fraction and response to aortic valve replacement. Am J Cardiol. 2011;107:1052-1057.
  8. Dahl J, Videbak L, Poulsen M, et al. Global strain in severe aortic valve stenosis relation to clinical outcome after aortic valve replacement. Circ Cardiovasc Imaging. 2012;5:613-620.
  9. Dahou A, Bartko P, Capoulade R, et al. Usefulness of global left ventricular longitudinal strain for risk stratification in low ejection fraction, low-gradient aortic stenosis results from the multicenter true or pseudo-severe aortic stenosis study. Circ Cardiovasc Imaging. 2015;8:1-24.
  10.  Delgado V, Tops LF, van Bommel RJ, et al. Strain analysis in patients with severe aortic stenosis and preserved left ventricular ejection fraction undergoing surgical valve replacement. Eur. Heart J. 2009;30:3037-3047.
  11.  Dimitriu-Leen A, Scholte A, Katsanos S, et al. Influence of myocardial ischemia extent on left ventricular global longitudinal strain in patients after st-segment elevation myocardial infarction. Am J Cardiol. 2017;119:1-6.
  12.  Donal E, Thebault C, O’Connor K, et al. Impact of aortic stenosis on longitudinal myocardial deformation during exercise. Eur J Echocardiogr. 2011;12:235-241.
  13.  Greenberg NL, Firstenberg MS, Castro PL, et al. Doppler-derived myocardial systolic strain rate is a strong index of left ventricular contractility. Circulation. 2002;105:99-105.
  14.  Iung B, Baron G, Butchart EG. et al A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231-1243.
  15.  Kitai T, Honda S, Okada Y, et al. Clinical outcomes in nonsurgically managed patients with very severe versus severe aortic stenosis. Heart. 2011;97:2029-2032.
  16.  Krayenbuehl HP, Hess OM, Ritter M, et al. Left ventricular systolic function in aortic stenosis. Eur. Heart J. 1988;9(E):19-23.
  17.  Lakoumentas J, Panou F, Vasiliki K, et al. The Tei Index of Myocardial Performance: Applications in Cardiology. Hellenic. J. Cardiol. 2005;46:52-58.
  18.  Lancellotti P, Donal E, Magne J, et al. Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay. Heart. 2010;96:1364-1371.
  19.  Lang R, Badano L, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1-39.
  20.  Lafitte S, Perlant M, Reant P et al. Impact of impaired myocardial deformations on exercise tolerance and prognosis in patients with asymptomatic aortic stenosis. Eur J Echocardiogr. 2009;10:414-419.
  21.  Lech A, Dobrowolski P, Klisiewicz A, et al. Exercise-induced changes in left ventricular global longitudinal strain in asymptomatic severe aortic stenosis. Kardiologia Polska. 2017;75(2):143-149.
  22.  Monin JL, Quere JP, Monchi M, et al. Lowgradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation. 2003;108:319-324.
  23.  Mor-Avi V, Lang RM, Badano LP, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. J Am Soc Echocardiogr. 2011;24:277-313.
  24.  Ng AC, Delgado V, Bertini M, et al. Alterations in multidirectional myocardial functions in patients with aortic stenosis and preserved ejection fraction: a twodimensional speckle tracking analysis. Eur Heart J. 2011;32:1542-50.
  25.  Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:1-96.
  26.  Notomi Y, Lysyansky P, Setser R.M, et al. Measurement of ventricular torsion by two-dimensional ultrasound speckle tracking imaging. J Am Coll Cardiol. 2005;45:2034-2041.
  27.  Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. 2005;111:3290-3295.
  28.  Pibarot P, Dumesnil JG. Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction. J Am Coll Cardiol. 2012;60:1845-1853.
  29.  Quere JP, Monin JL, Levy F, et al. Influence of preoperative left ventricular contractile reserve on postoperative ejection fraction in low-gradient aortic stenosis. Circulation. 2006;113:1738-1744.
  30.  Quinones M, Otto C, Stoddard M, et al. Recommendations for Quantification of Doppler Echocardiography: A Report From the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J. Am. Soc. Echocardiogr. 2002;15:167-184.
  31.  Rajappan K, Rimoldi OE, Dutka DP, et al. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation. 2002;105:470-476.
  32.  Sato K, Seo Y, Ishizu T, et al. Prognostic value of global longitudinal strain in paradoxical low-flow, low-gradient severe aortic stenosis with preserved ejection fraction. Circ J. 2014;78:2750-2759.
  33.  Teske AJ, De Boeck BW, Melman PG, et al. Echocardiographic quantification of myocardial function using tissue deformation imaging, a guide to image acquisition and analysis using tissue Doppler and speckle tracking. Cardiovasc Ultrasound. 2007;5:27.
  34.  Tribouilloy C, Levy F, Rusinaru D, et al. Outcome after aortic valve replacement for lowflow/ low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol. 2009;53:1865-1873.
  35. Vahanian A, Alfieri O, Andreotti F. et al ESC Committee for Practice Guidelines(CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology(ESC); European Association for Cardio-Thoracic Surgery(EACTS). Guidelines on the management of valvular heart disease(version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology(ESC) and the European Association for Cardio-Thoracic Surgery(EACTS). Eur J Cardiothorac Surg. 2012;42:S1-S44.
  36.  Weidemann F, Jamal F, Kowalski M, et al. Can strain rate and strain quantify changes in regional systolic function during dobutamine infusion, B-blockade, and atrial pacing-implications for quantitative stress echocardiography. J Am Soc Echocardiogr. 2002;15:416-424.
  37.  Yingchoncharoen T, Gibby C, Rodriguez LL, et al. Association of myocardial deformation with outcome in asymptomatic aortic stenosis with normal ejection fraction. Circ Cardiovasc Imaging. 2012;5:719-725.

 

[PDF] [Contents]  

  

 

Gender and age features in adults with congenital heart disease

I.G. Lebid

References

 

  1. Bugaenko VV. Gender-specific features of the diagnosis, course and treatment of coronary heart disease. Ukrainian Journal of Cardiology. 2015;6:100-112. (in Rus.)
  2. Klester EB, Ivanov OA, Budnev DS, Elykomov VA. Prevalence of comorbidities and their influence on complications and outcomes of coronary bypass surgery for coronary heart disease in gender perspective. Cardiovascular Therapy and Prevention. 2016;15(2):32-37. (in Rus.)
  3. Lebid I, Rudenko N, Yemets I. Kyiv UCCC,2015. 72p. (in Ukr.)
  4. Rudenko NM, Maksymenko AV, Bohuta LYu.  Medychna dopomoha doroslym patsiientam z vrodzhenymy vadamy sertsia. Metodychni rekomendatsii. Kyiv, 2011. 84 p. (in Ukr.).
  5. Siromakha SO, Rudenko KV, Zalevskyi VP. Dosvid likuvannia krytychnykh vrodzhenykh vad sertsia ta sprychynenykh nymy krytychnykh staniv yak element nevidkladnoi abo ekstrenoi kardiokhirurhii. Visnyk sertsevo-sudynnoi khirurhii -Cardiovascular Surgery Herald. 2014;22:320-325. (in Ukr.).
  6. Engelings CC, Helm PC, Abdul-Khaliq H, Asfour B, Bauer UMM, Baumgartner H, Kececioglu D, Körten M-A, Diller GP, Tutarel O. Cause of death in adults with congenital heart disease - An analysis of the German National Register for Congenital Heart Defects. International Journal of Cardiology.2016;211:31-36.
  7. International Paediatric and Congenital Cardiac Code (IPCCC). http://www.IPCCC.net
  8. Kochilas LK, Vinocur JM. Menk JS. Age-Dependent Sex Effects on Outcomes After Pediatric Cardiac Surgery. J Am Heart Assoc. 2014;3:1-11.
  9. Ministeri M, Alonso-Gonzalez R, Swan L, Dimopoulos K. Common long-term complications of adult congenital heart disease: avoid falling in a H.E.A.P. Expert Rev Cardiovasc Ther. 2016;14:445-462.
  10. Moon JR, Song J, Huh J, Kang IS, Park SW, Chang SA, Yang JH, Jun TG. Analysis of Cardiovascular Risk Factors in Adults with Congenital Heart Disease. Korean Circ J. 2015.Sep;45(5):416-423.
  11. Ntiloudi D, Giannakoulas G, Parcharidou D, Panagiotidis T, Gatzoulis M.A, Karvounis H. Adult congenital heart disease: A paradigm of epidemiological change. International Journal of Cardiology. 2016;218:269-274.
  12. Rodriguez FH. 3rd, Marelli AJ. The epidemiology of heart failure in adults with congenital heart disease. Heart Fail. Clin. 2014;10:1-7.
  13. Warnes CA. Sex differences in congenital heart disease: should a woman be more like a man? Circulation. 2008;118:3-5.
  14. Webb G, Mulder B, Aboulhosn J, Daniels CJ, Elizari MA, Hong G, Horlick E, Landzberg MJ, Marelli AJ, O'Donnell C,  Oechslin E.N, Pearson D.D, Pieper E.P.G, Saxena A, Schwerzmann M, Stout K.K, Warnes C.A, Khairy P. The care of adults with congenital heart disease across the globe: Current assessment and future perspective: A position statement from the International Society for Adult Congenital Heart Disease (ISACHD). International Journal of Cardiology. 2015;195:326-333.
  15. Zomer A.C, Verheugt C.L, Vaartjes I, Uiterwaal C.S.P.M, Langemeijer M.M, Koolbergen D.R, Hazekamp M.G, van Melle J.P, Konings T.C, Bellersen L, Grobbee D.E. Mulder  B.J.M. Surgery in Adults With Congenital Heart Disease. Circulation. 2011;124:2195-2201.

 

[PDF] [Contents]  

  

 

The effectiveness of static balloon atrioseptostomy for correcting hemodynamics in complex congenital heart diseases

O.O. Motrechko, A.V. Maksymenko, Yu.L. Kuzmenko, M.P. Radchenko, N.M. Rudenko

References 

  1. Al Maluli H, De Stephan ChM, Alvarez RJJr, Sandoval J. Atrial septostomy: a contemporary. Clin. Cardiology. 2015;38(6):395-400.
  2. Allen HD, Beekman RHIII, Garson AJr, et al. Pediatric therapeutic cardiac catheterization. A statement for healthcare professionals from the council on cardiovascular disease in the young, American Heart Association. Circulation. 1998;97:609-625.
  3. Mitchell SE, Kan JS, Anderson JH, et al. Atrial septostomy: stationary angioplasty balloon technique. Pediatr. Res. 1986;20:173а.
  4. Moscucci M. Complications of cardiovascular procedures risk factors management and bailout techniques. Philadelphia: Wolters Kluwer / Lippincott Williams and Wilkins, 2012;VI:321-343.
  5. O'Byrne ML, Glatz AC, Rossano JW, et al. Middle-term results of trans-catheter creation of atrial communication in patients receiving mechanical circulatory support. Catheter Cardiovasc. Interv. 2015;85(7):1189-1195.
  6. Shrivastava S, Radhakrishnan S, Dev V, et al. Balloon dilatation of atrial septum in complete transposition of great artery: a newtechnique. Indian Heart J. 1987;39:298-300.
  7. Sugiyama H, Fujimoto K, Ishii T, et al. Impact of novel balloon catheter on static balloon atrial septostomy with double balloon technique in infants with congenital heart disease. Circulation J. Off. J. Japan. Circulation Society. 2015;79:2368-2371.
  8. Tomita H, Hatakeyama K, Soda W, et al. Static balloon atrial septostomy with buddy wire technique: a case report. J. Cardiol. 2007;50 (4):259-262.
  9. Webber SA, Culham JAG, Sandor GGS, Patterson M.W. Balloon dilatation of restrictive interatrial communications in congenital heart disease. Br Heart J. 1991;65:346-348.

  

[PDF] [Contents]  

  

 

Extending treatment choices for thoracic endovascular aortic repair. Experience from a large case series at a busy European endovascular center

G.B. Torsello, G.F. Torsello

References 

  1. Arnaoutakis GJ, Schneider EB, Arnaoutakis DJ, et al. Influence of gender on outcomes after thoracic endovascular aneurysm repair. J Vasc Surg. 2014;59:45-51.
  2. Chaikof EL, Blankensteijn JD, Harris PL, et al. Reporting standards for endovascular aortic aneurysm repair. J. Vasc. Surg. 2002;35:1048-1060.
  3. Fairman RM, Criado F, Farber M, et al. Pivotal results of the Medtronic Vascular Talent Thoracic Stent Graft System: the VALOR Trial. J. Vasc. Surg. 2008;48:546-554.
  4. Illig KA, Ohki T, Hughes GC, et al. One-year outcomes from the international multicenter study of the Zenith Alpha Thoracic Endovascular Graft for thoracic endovascular repair. J Vasc Surg. 2015;62:1485-1494.
  5. Jackson BM, Woo EY, Bavaria JE, et al. Gender analysis of the pivotal results of the Medtronic Talent Thoracic Stent Graft System (VALOR) trial. J Vasc Surg. 2011;54:358-363.
  6. Katzen BT, Dake MD, MacLean AA, et al. Endovascular repair of abdominal and thoracic aortic aneurysms. Circulation. 2005;112:1663-1675.
  7. Makaroun MS, Dillavou ED, Wheatley GH, et al. Five-year results of endovascular treatment with the Gore TAG device compared with open repair of thoracic aortic aneurysms. J Vasc Surg. 2008;47:912-918.
  8. Matsumura JS, Cambria RP, Dake MD, et al. International controlled clinical trial of thoracic endovascular aneurysm repair with the Zenith TX2 endovascular graft: 1-year results. J Vasc Surg. 2008;47:247-257.
  9. Nienaber CA, Kische S, Ince H. Thoracic aortic stent-graft devices: problems, failure modes, and applicability. Semin Vasc Surg. 2007;20:81-89.
  10. Orandi BJ, Dimick JB, Deeb GB, et al. A population-based analysis of endovascular versus open thoracic aortic aneurysm repair. J Vasc Surg. 2009;49:1112-1116.
  11. Patterson B, Holt P, Nienaber C, et al. Aortic pathology determines midterm outcome after endovascular repair of the thoracic aorta: report from the Medtronic Thoracic Endovascular Registry (MOTHER) database. Circulation. 2013;127:24-32.
  12. Torsello GF, Austermann M, Van Aken HK, et al. Initial clinical experience with the Zenith Alpha Stent Graft. J Endovasc Therapy. 2015;22:153-159.
  13. Torsello GF, Torsello GB, Austermann M. Zenith TX2 Low Profile TAA Endovascular Graft: a next generation thoracic stent-graft. J Cardiovasc Surg. 2012;53:153-159.

  

[PDF] [Contents]  

  

 

Experience of instantaneous transaction coronary bypass surgery with carotid endarterectomy

B.M. Todurov, G.I. Kovtun, M.A. Taranov, A.I. Matvijchuk, О.М. Postupalsky, А.О. Shpachuk, S.O. Sheludko, O.V. Revenko, O.A. Loskutov

References 

  1. Belkin AA, Alasheev AM, Inyushkin SN. Transcranial Doppler ultrasound in intensive care. Petrozavodsk: Intel Tech, 2006. 103 p. (in Rus.).     
  2. Bernhard V, Johnson W, Peterson J. Simultaneous coronary artery bypass and carotid endarterectomy. Determinants of outcome. Tex. Heart Inst. J.  1994;21(2):119-124.
  3. Breuer AC, Furlan AJ, Hanson MR. Central nervous system complications of coronary artery bypass graft surgery: Prospective analysis of 421 patients. Stroke.  1983;14:682-687.
  4. Hanna J.P. Cardiac disease and embolic sources. Brain ischemia: basic concepts and clinical relevance. Ed. Caplan LR, Hanna JP, Furlan AJ.  Springer-Verlag,1995:299-315.
  5. Hertzer NR, Loop FD, Taylor PC. Combined myocardial revascularization and carotid endarterectomy: Operative and late results in 331 patients. J Thorac Cardiovasc Surg.  1983;85:577-589.
  6. Hogue CW, Palin CA, Arrowsmith JE. Cardiopulmonary bypass management and neurologic outcomes: an evidence-based appraisal of current practices. Anesthesia & Analgesia.  2006;103(1):21-37.
  7. Markus H.S. Cerebral perfusion and stroke. J Neurol Neurosurg Psychiatry.  2004;75(3):353-361.
  8. Pribán V, Fiedler J, Chlouba V, et al. Simultaneous carotid endarterectomy and coronary revascularization: indications and results. Rozhl Chir. 2011;90(1):67-72.
  9. Probasco J, Sahin B, Tran T, et al. The preoperative neurological evaluation. Neurohospitalist. 2013;3(4):209-220.
  10. Vermeulen F, Hamerlijnck R, Defauw J, et al. Combined carotid and coronary revascularization. Acta Chir Belg.  1993;93(5):239-241.

[PDF] [Contents]  

  

 

The case of the unusual progression of the left atrial malignant tumor

R.M. Vitovsky, V.V. Isaenko, O.A. Pishchurin, V.F. Onishchenko, O.Z. Paratsiy, I.G. Yakovenko, D.N. Dyadyun, T.I. Dedkova

References 

  1. Kiprensky AYu, Nechaenko MA. Diagnostics and surgical treatment of non-myxomatous heart tumors. Kazan Medical J. 2014;95(6):821-830. (in Rus.).
  2. Knyshov GV, Vitovsky RM, Zakharova VP. Tumors of the heart. Кyiv, 2005. 256 p. (in Rus.).
  3. Anvari MS, Naderan M, et al. Clinicopathologic review of non-myxoma cardiac tumors: a 10-year single-center experience. Cardiology. 2014;129:199-202.
  4. Diaz А, Di Salvo C, et al. Left atrial and right ventricular myxoma: an uncommon presentation of a rare tumour. Interact Cardiovasc Thorac Surg. 2011;12(4):622-623.
  5. Hoffmeier A, Sindermann JR, Scheld HH, et al. Cardiac tumors - diagnosis and surgical treatment. Deutsches Ärzteblatt International. 2014;111(12):205-211.
  6. Neragi-Miandoab S, Kim J, Vlahakes GJ. Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clin Oncol (R. Coll. Radiol.). 2007;19(10):748-756. 
  7. Shanmugam G. Primary cardiac sarcoma. Eur J Cardiothorac Surg. 2006;29(6):925-932.
  8. Simpson L, Kumar SK, Okuno SH, et al. Malignant primary cardiac tumors: review of a single institution experience. Cancer. 2008;112(11):2440-2446.
  9. Yuan SM, Shinfeld A, Lavee J, et al. Imaging morphology of cardiac tumours. Cardiol J. 2009;16(1):26-35.

[PDF] [Contents]  

  

 

Occlusion of the left subclavian artery as a reason of angina pectoris recurrence after coronary artery bypass grafting

V.I. Ursulenko, O.K. Gogayeva, L.S. Dzakhoieva

References 

  1. Fitzgibbon GM, Kafka HP, Leach AJ, et al. Coronary bypass graft fate and patient outcome: angiographic follow up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28:616-626.
  2. Fitzsimmons PJ, Terry Е, Scott RC. Coronary-Subclavian Steal: Case Series and Review of Diagnostic and Therapeutic Strategies. Angiology. 2007;58(2):242-248.
  3. Marquardt F, Hammel D, Engel H.J. The coronary-subclavian-vertebral steal syndrome (CSVSS). Clin Res Cardiol. 2006;95 (1). Р. 48-53.
  4. Nwasokwa O.N. Coronary artery bypass graft disease. Ann Intern Med. 1995;123:528-545.
  5. Sadek MM, Ravindran A, Marcuzzi DW. Complete occlusion of the proximal subclavian artery post-CABG: presentation and treatment. Can J Cardiol. 2008;24 (7):591-592.
  6. Taggart DP. Current status of arterial grafts for coronary artery bypass grafting. Ann Cardiothorac Surg. 2013;2 (4):427-430.
[PDF] [Contents]  

  

 

ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/ STS 2016 Appropriate use criteria for coronary revascularization in patients with acute coronary syndromes

Coronary Revascularization Writing Group: M. Patel (Chair), J. Calhoon, G. Dehmer, J. Grantham, T. Maddox, D. Maron, P. Smith

References 

  1. Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/ SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2012;59:857-881.
  2.  O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:e78-140.
  3. Jneid H, Anderson JL, Wright RS, et al. 2012 ACCF/ AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2012;60:645-681.
  4.  Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;64:1929-1949.
  5. Levine GN, O’Gara PT, Bates ER, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2016;67:1235-1250.
  6. Engstrom T, Kelbaek H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015;386:665-671.
  7. Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2015;65:963-972.
  8. Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med.  2013;369:1115-1123.
  9. Bradley SM, Spertus JA, Kennedy KF, et al. Patient selection for diagnostic coronary angiography and hospital-level percutaneous coronary intervention appropriateness: insights from the National Cardiovascular Data Registry. JAMA Intern. Med. 2014;174:1630-1639.
  10. Chan PS, Patel MR, Klein LW, et al. Appropriateness of percutaneous coronary intervention. JAMA. 2011;306:53-61.
  11. Desai NR, Bradley SM, Parzynski CS, et al. Appropriate use criteria for coronary revascularization and trends in utilization, patient selection, and appropriateness of percutaneous coronary intervention. JAMA. 2015;314:2045-2053.
  12. Hendel RC, Patel MR, Allen JM, et al. Appropriate use of cardiovascular technology: 2013 ACCF appropriate use criteria methodology update. J Am Coll Cardiol. 2013;61:1305-1317.
  13. Smith SCJr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2006;47:2130-2139.
  14. Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106:388-391.
  15. Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2007;115:114-126.
  16. Adult Treatment Panel III. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
  17. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
  18. Harold JG, Bass TA, Bashore TM, et al. ACCF/ AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise the 2007 Clinical Competence Statement on Cardiac Interventional Procedures). J Am Coll Cardiol. 2013;62:357-396.
  19. Hillis LD, Smith P, Anderson J, et al. 2011 ACCF/ AHA guidelines for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;58:e123-210.
  20. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58:e44-122.
  21. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64:e139-228.
  22. TIMI Study Group. Available at: http://www.timi. org. Accessed March 15, 2011.
  23. Chewning B, Bylund CL, Shah B, et al. Patient preferences for shared decisions: a systematic review. Patient. Educ. Couns. 2012;86:9-18.
  24. Lin GA, Fagerlin A. Shared decision making: state of the science. Circ. Cardiovasc. Qual. Outcomes. 2014;7:328-334.
  25. Ting HH, Brito JP, Montori VM. Shared decision making: science and action. Circ. Cardiovasc. Qual. Outcomes. 2014;7:323-327.
  26. Buchanan A. Medical paternalism. Philos Public Aff. 1978;7:370-390. 
[PDF] [Contents]  

Crossref Member Badge

© "Cardiac Surgery and Interventional Cardiology" Ukrainian scientific and practical peer-reviewed journal, 2023